Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 Nov 24;4(5890):443–446. doi: 10.1136/bmj.4.5890.443

Use of Medroxyprogesterone Acetate as a Contraceptive in conjunction with Early Postpartum Rubella Vaccination

David S Sharp, Helen Macdonald
PMCID: PMC1587555  PMID: 4758444

Abstract

During a 12-month period 170 women received early postpartum rubella vaccination. An injectable “depot” progestogen was given to each of these patients for contraceptive purposes at the same time as the vaccine was administered. Subsequent observations showed that the progestogen was effective as a contraceptive in this context and that it did not appear to affect the immune response of the patients to the vaccine.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin J. A., Freestone D. S. Risk of early post-partum pregnancy in context of post-partum vaccination against rubella. Lancet. 1971 Aug 14;2(7720):366–367. doi: 10.1016/s0140-6736(71)90075-4. [DOI] [PubMed] [Google Scholar]
  2. Cradock-Watson J. E., Bourne M. S., Vandervelde E. M. IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique. J Hyg (Lond) 1972 Sep;70(3):473–485. doi: 10.1017/s0022172400063063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hutchinson D. N., Thompson K. M. Continuous rabbit kidney cell cultures in the diagnosis of rebella infections. Mon Bull Minist Health Public Health Lab Serv. 1965 Nov;24:385–391. [PubMed] [Google Scholar]
  4. Jeppsson S. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent. Acta Obstet Gynecol Scand. 1972;51(3):257–263. doi: 10.3109/00016347209156856. [DOI] [PubMed] [Google Scholar]
  5. Jones J. R., Lonky S. Use of injectable contraceptive immediately post partum. N Y State J Med. 1971 Oct;71(19):2279–2282. [PubMed] [Google Scholar]
  6. MacDonald H., Thompson K. M., Tobin J. O. Vaccination of women with the Cendehill strain of rubella virus. Practitioner. 1971 Jul;207(237):57–66. [PubMed] [Google Scholar]
  7. Mair H. J., Buchan A. R. Rubella vaccination and termination of pregnancy. Br Med J. 1972 Nov 4;4(5835):271–273. doi: 10.1136/bmj.4.5835.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Powell L. C., Jr, Seymour R. J. Effects of depo-medroxyprogesterone acetate as a contraceptive agent. Am J Obstet Gynecol. 1971 May 1;110(1):36–41. doi: 10.1016/0002-9378(71)90210-9. [DOI] [PubMed] [Google Scholar]
  9. Thompson K. M., Tobin J. O. Isolation of rubella virus from abortion material. Br Med J. 1970 May 2;2(5704):264–266. doi: 10.1136/bmj.2.5704.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. el-Mahgoub S., Karim M., Ammar R. Long-term use of depot medroxy progesterone acetate as a contraceptive. Acta Obstet Gynecol Scand. 1972;51(3):251–255. doi: 10.3109/00016347209156855. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES